Not so fast: research on infectious links to MS questioned.
Vastag
B
B
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002494:Central Nervous System Infections / Q000134:cerebrospinal fluid / Q000150:complications* / Q000188:drug therapy; D023521:Chlamydophila Infections / Q000134:cerebrospinal fluid / Q000150:complications* / Q000188:drug therapy; D016993:Chlamydophila pneumoniae / Q000302:isolation & purification; D002986:Clinical Trials as Topic; D006566:Herpesviridae Infections / Q000134:cerebrospinal fluid / Q000150:complications* / Q000188:drug therapy; D015654:Herpesvirus 6, Human / Q000302:isolation & purification; D006801:Humans; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000382:microbiology* / Q000821:virology*
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents